Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GALOP II Protocol for the Treatment of Unilateral Retinoblastoma

NCT03475121 is registered in ClinicalTrials.gov with Hospital JP Garrahan as lead sponsor.

NCT NCT03475121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03475121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GALOP II Protocol for the Treatment of Unilateral Retinoblastoma
Lead sponsor
Hospital JP Garrahan
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2018
Completion date
March 28, 2025
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unilateral retinoblastoma